RU2002118709A - Амфифильные полимеры и полипептидные конъюгаты, включающие их - Google Patents
Амфифильные полимеры и полипептидные конъюгаты, включающие их Download PDFInfo
- Publication number
- RU2002118709A RU2002118709A RU2002118709/15A RU2002118709A RU2002118709A RU 2002118709 A RU2002118709 A RU 2002118709A RU 2002118709/15 A RU2002118709/15 A RU 2002118709/15A RU 2002118709 A RU2002118709 A RU 2002118709A RU 2002118709 A RU2002118709 A RU 2002118709A
- Authority
- RU
- Russia
- Prior art keywords
- compound according
- oligomer
- fragment
- lysine residue
- paragraphs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/459,443 | 1999-12-13 | ||
| US09/459,443 US6638906B1 (en) | 1999-12-13 | 1999-12-13 | Amphiphilic polymers and polypeptide conjugates comprising same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2002118709A true RU2002118709A (ru) | 2004-02-27 |
Family
ID=23824795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002118709/15A RU2002118709A (ru) | 1999-12-13 | 2000-12-11 | Амфифильные полимеры и полипептидные конъюгаты, включающие их |
Country Status (18)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425138D0 (en) | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| US6703381B1 (en) * | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| US20090281023A9 (en) * | 2001-06-04 | 2009-11-12 | Nobex Corporation | Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment |
| US6828305B2 (en) * | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| EP1468116A2 (en) | 2002-01-16 | 2004-10-20 | Dynal Biotech ASA | Method for isolating nucleic acids and protein from a single sample |
| US20040062748A1 (en) * | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| US8129330B2 (en) | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
| EP1569683B1 (en) * | 2002-11-26 | 2010-03-03 | Biocon Limited | Modified natriuretic compounds, conjugates, and uses thereof |
| GB0229287D0 (en) * | 2002-12-16 | 2003-01-22 | Dna Res Innovations Ltd | Polyfunctional reagents |
| CN1761680A (zh) | 2002-12-26 | 2006-04-19 | 武田药品工业株式会社 | 肿瘤迁移抑制素衍生物及其用途 |
| US7553930B2 (en) | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
| CA2544156C (en) * | 2003-10-29 | 2012-07-10 | Altus Pharmaceuticals Inc. | Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain |
| AU2005257484A1 (en) | 2004-06-25 | 2006-01-05 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| US8329958B2 (en) | 2004-07-02 | 2012-12-11 | Biocon Limited | Combinatorial synthesis of PEG oligomer libraries |
| US8168222B2 (en) * | 2004-09-07 | 2012-05-01 | Board Of Regents Of The University Of Nebraska | Amphiphilic polymer-protein conjugates and methods of use thereof |
| WO2006076471A2 (en) * | 2005-01-12 | 2006-07-20 | Nobex Corporation | Bnp conjugates and methods of use |
| CA2606270A1 (en) * | 2005-04-19 | 2006-10-26 | Massachusetts Institute Of Technology | Amphiphilic polymers and methods of use thereof |
| US20070026383A1 (en) * | 2005-07-15 | 2007-02-01 | Quintessence Biosciences, Inc. | Methods and compositions for extracting membrane proteins |
| US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| TWI404726B (zh) | 2006-10-25 | 2013-08-11 | Takeda Pharmaceutical | 腫瘤轉移抑制素衍生物及其用途 |
| PT2314609T (pt) * | 2008-07-30 | 2017-03-06 | Takeda Pharmaceuticals Co | Derivado de metastina e sua utilização |
| MX2013009859A (es) | 2011-03-01 | 2014-02-28 | Novo Nordisk As | Ligandos dr3 antagonicos. |
| CN103740659B (zh) * | 2012-05-10 | 2015-06-03 | 江南大学 | 一种提高酶热稳定性的方法 |
| CN103740661B (zh) * | 2012-05-10 | 2015-06-03 | 江南大学 | 一种提高酶热稳定性的方法 |
| US20140039158A1 (en) * | 2012-07-25 | 2014-02-06 | Belrose Pharma, Inc. | Polymeric conjugates and methods of preparing the same |
| CN106729735B (zh) * | 2017-03-09 | 2020-05-12 | 国家纳米科学中心 | 一种pH敏感的多肽聚合物及其制备方法和应用 |
| BR112020021134A2 (pt) * | 2018-04-16 | 2021-03-23 | Merck Patent Gmbh | aditivos para formulações de proteínas para aprimorar estabilidade térmica |
| KR20240026573A (ko) * | 2022-08-22 | 2024-02-29 | 부산대학교 산학협력단 | 폴리소르베이트-숙신산-카르니틴 복합체 및 이를 포함하는 생리활성 물질 또는 약물 전달용 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5411947A (en) | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
| US5407683A (en) | 1990-06-01 | 1995-04-18 | Research Corporation Technologies, Inc. | Pharmaceutical solutions and emulsions containing taxol |
| IE912365A1 (en) * | 1990-07-23 | 1992-01-29 | Zeneca Ltd | Continuous release pharmaceutical compositions |
| WO1994005282A1 (en) | 1992-09-04 | 1994-03-17 | The Scripps Research Institute | Water soluble taxol derivatives |
| US5439686A (en) | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
| US6191105B1 (en) | 1993-05-10 | 2001-02-20 | Protein Delivery, Inc. | Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin |
| US5681811A (en) * | 1993-05-10 | 1997-10-28 | Protein Delivery, Inc. | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| EP0862631A1 (en) | 1995-10-26 | 1998-09-09 | The Board Of Regents, The University Of Texas System | Luminal cholecystokinin-releasing factor |
| JP3737518B2 (ja) | 1996-03-12 | 2006-01-18 | ピージー−ティーエックスエル カンパニー， エル．ピー． | 水溶性パクリタキセルプロドラッグ |
| US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| IL133585A0 (en) | 1997-06-20 | 2001-04-30 | Baker Norton Pharma | Soluble prodrugs of paclitaxel |
| US6495514B1 (en) * | 1998-01-21 | 2002-12-17 | Mercer University | Method for reducing inflammation and inducing an analgesic effect and compounds thereof |
| US6309633B1 (en) | 1999-06-19 | 2001-10-30 | Nobex Corporation | Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same |
| KR100345214B1 (ko) * | 1999-08-17 | 2002-07-25 | 이강춘 | 생체적합성 고분자가 수식된 펩타이드의 비점막 전달 |
| US6713452B2 (en) * | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
-
1999
- 1999-12-13 US US09/459,443 patent/US6638906B1/en not_active Expired - Fee Related
-
2000
- 2000-12-11 IL IL15011900A patent/IL150119A0/xx unknown
- 2000-12-11 CA CA002394928A patent/CA2394928A1/en not_active Abandoned
- 2000-12-11 WO PCT/US2000/033592 patent/WO2001041812A2/en not_active Application Discontinuation
- 2000-12-11 CN CN00818964A patent/CN1434725A/zh active Pending
- 2000-12-11 KR KR1020027007500A patent/KR20020068053A/ko not_active Application Discontinuation
- 2000-12-11 JP JP2001543156A patent/JP2003516366A/ja active Pending
- 2000-12-11 BR BR0016339-2A patent/BR0016339A/pt not_active IP Right Cessation
- 2000-12-11 MX MXPA02005885A patent/MXPA02005885A/es unknown
- 2000-12-11 HU HU0300133A patent/HUP0300133A2/hu unknown
- 2000-12-11 CZ CZ20021990A patent/CZ20021990A3/cs unknown
- 2000-12-11 PL PL00359174A patent/PL359174A1/xx unknown
- 2000-12-11 RU RU2002118709/15A patent/RU2002118709A/ru not_active Application Discontinuation
- 2000-12-11 AU AU20875/01A patent/AU2087501A/en not_active Abandoned
- 2000-12-11 EP EP00984215A patent/EP1237580A2/en not_active Withdrawn
-
2002
- 2002-06-12 NO NO20022793A patent/NO20022793L/no not_active Application Discontinuation
-
2003
- 2003-02-21 HK HK03101329.7A patent/HK1049283A1/zh unknown
- 2003-06-07 ZA ZA200204603A patent/ZA200204603B/xx unknown
- 2003-08-04 US US10/633,966 patent/US20040092449A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1434725A (zh) | 2003-08-06 |
| HK1049283A1 (zh) | 2003-05-09 |
| KR20020068053A (ko) | 2002-08-24 |
| BR0016339A (pt) | 2002-08-27 |
| NO20022793D0 (no) | 2002-06-12 |
| WO2001041812A3 (en) | 2002-03-21 |
| CZ20021990A3 (cs) | 2002-11-13 |
| US20040092449A1 (en) | 2004-05-13 |
| IL150119A0 (en) | 2002-12-01 |
| JP2003516366A (ja) | 2003-05-13 |
| EP1237580A2 (en) | 2002-09-11 |
| NO20022793L (no) | 2002-08-13 |
| PL359174A1 (en) | 2004-08-23 |
| CA2394928A1 (en) | 2001-06-14 |
| HUP0300133A2 (en) | 2003-05-28 |
| ZA200204603B (en) | 2003-11-26 |
| US6638906B1 (en) | 2003-10-28 |
| MXPA02005885A (es) | 2002-10-23 |
| AU2087501A (en) | 2001-06-18 |
| WO2001041812A2 (en) | 2001-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002118709A (ru) | Амфифильные полимеры и полипептидные конъюгаты, включающие их | |
| EP2269654A3 (en) | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties | |
| US6262253B1 (en) | Vitamin B12 conjugates with gcsf, analogues thereof and pharmaceutical compositions | |
| CN1126441A (zh) | 使用聚合物放大维生素b12吸收系统 | |
| JP2010510236A5 (US06638906-20031028-C00029.png) | ||
| EP2335715A3 (en) | Pancreatic polypeptide family motifs and polypeptides comprising the same | |
| UA66857C2 (uk) | КОН'ЮГАТ ПОЛІОЛ-<font face="Symbol">b</font>-ІНТЕРФЕРОН, СПОСІБ ОДЕРЖАННЯ КОН'ЮГАТУ ПОЛІОЛ-<font face="Symbol">b</font>-ІНТЕРФЕРОН ТА СПОСІБ ЛІКУВАННЯ ІНФЕКЦІЙНИХ ХВОРОБ, ПУХЛИН І АУТОІМУННИХ І ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ | |
| JP2003113113A5 (US06638906-20031028-C00029.png) | ||
| JP2010518017A5 (US06638906-20031028-C00029.png) | ||
| CA2452923A1 (en) | Peptide-based compounds for targeting integrin receptors | |
| CA2345027A1 (en) | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility | |
| DE60235010D1 (de) | Monodisperse gemische aus calcitonin-arzneimittel-oligomer-konjugaten mit polyethylenglycol, ihre verwendung und verfahren zu ihrer herstellung | |
| ATE196314T1 (de) | Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit | |
| EP2112165A3 (en) | Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases | |
| JP2005524657A5 (US06638906-20031028-C00029.png) | ||
| JP2004534782A5 (US06638906-20031028-C00029.png) | ||
| JP2005504006A5 (US06638906-20031028-C00029.png) | ||
| EP2301959A3 (en) | Motif-grafted hybrid polypeptides and uses thereof | |
| WO2001015736A3 (en) | Interferon-beta conjugates | |
| WO2008027944A3 (en) | Antigenic protein conjugates and process for preparing same | |
| JP2006523709A5 (US06638906-20031028-C00029.png) | ||
| DE60027905D1 (de) | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung | |
| WO2003037272A3 (en) | Thymosin alpha 1 peptide/polymer conjugates | |
| WO2001083693A3 (en) | Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses | |
| JP2002522512A5 (US06638906-20031028-C00029.png) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20050128 |